MedPage Today) — NEW YORK CITY — An investigational drug targeting senescent cells achieved sustained improvement in visual acuity in patients with diabetic macular edema (DME) or neovascular age-related macular degeneration (AMD), a small…
Read More
![‘Senolytic’ Therapy Shows Promise in Neovascular Eye Disease](https://alexapost.com/wp-content/uploads/2022/07/625-senolytic-therapy-shows-promise-in-neovascular-eye-disease.jpg)